LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW)

CUSIP: 55068A118

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
5,570,448
Share change
+520,949
Total reported value
$812,940
Price per share
$0.15
Number of holders
29
Value change
-$95,553
Number of buys
7
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 55068A118?
CUSIP 55068A118 identifies LUXAW - LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW) as of Q2 2022

As of 30 Jun 2022, LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,570,448 shares. The largest 10 holders included COWEN AND COMPANY, LLC, Shaolin Capital Management LLC, Wolfswood Holdings, LLC, Balyasny Asset Management LLC, Fort Baker Capital Management LP, MYDA Advisors LLC, Sage Rock Capital Management LP, Castle Creek Arbitrage, LLC, AQR Arbitrage LLC, and BBR PARTNERS, LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.